Royalty Pharma PLC (MEX:RPRX)
MXN 528.5 0 (0%) Market Cap: 229.61 Bil Enterprise Value: 416.39 Bil PE Ratio: 10.02 PB Ratio: 1.66 GF Score: 72/100

Royalty Pharma PLC at Evercore ISI HealthCONx Conference (Virtual) Transcript

Dec 02, 2020 / 01:00PM GMT
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Excellent. Well, listen, good morning, guys. Thanks for joining us. Super excited to have Royalty Pharma management join us this morning.

(technical difficulty)

Before we do, Pablo, would love to have you perhaps kick things off and highlight for us the key things high on your priority list as we head into the new year.

Pablo Legorreta
Royalty Pharma plc - Founder, Chairman of the Board & CEO

Of course, Umer. Thank you. And good morning, everyone. It is a pleasure to be here at the Evercore ISI Healthcare Conference. I look forward to talking -- to taking your questions. But first, for those who are less familiar with our company, I thought it would be helpful to spend a few minutes explaining why Royalty Pharma is, not only a different kind of biopharma company, but also a unique investment proposition.

Let me start at the beginning. I founded the company in 1996, having recognized the large untapped

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot